We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

INTUITIVE SURGICAL

Intuitive Surgical develops, manufactures and markets robotic surgical systems, advanced instruments and accessories ... read more Featured Products: More products

Download Mobile App




Robotic Surgery Reduces Blood Loss Risk in Obese Patients

By HospiMedica International staff writers
Posted on 07 Jun 2016
Researchers at the Loyola University Health System (Chicago, IL, ISA) identified 9,108 obese patients from the 2009-2010 Nationwide Inpatient Sample (NIS) who underwent radical prostatectomy. More...
Of these, 60.4% underwent RARP, and 39.6% underwent open radical prostatectomy (ORP). The primary outcome was the presence of peri-operative adverse events, such as surgical complications, blood transfusion, and prolonged length of stay.

The results showed that when compared with patients who underwent ORP, patients undergoing RARP were 83% less likely to require blood transfusions, and 72% less likely to require prolonged hospital stays. RARP did not, however, reduce the risk of infections, and both approaches were associated with similar odds of developing a complication. The study was published in the May 2016 issue of Current Urology.

“For urologists, the finding that robotic and open surgery have similar complication rates implies that both techniques remain interchangeable. The surgeon's comfort level should dictate which surgical approach is used,” concluded lead author Gopal Gupta, MD, an assistant professor in the department of urology. “For obese prostate cancer patients, the broad findings suggest that both surgical approaches are feasible and safe.”

RARP uses the Intuitive Surgical (Sunnyvale, CA, USA) da Vinci minimally invasive surgery system. The advantages of RARP include improved cosmetic result, less blood loss, briefer and less intense post-operative convalescence, and reduced hospitalization costs. It is also the basis of a "nerve-sparing" procedure called the Veil of Aphrodite, developed to minimize the erectile dysfunction common in men after undergoing traditional radical prostatectomy.

Related Links:
Loyola University Health System
Intuitive Surgical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.